Sensei Biotherapeutics (SNSE)

• Market cap: $34.9M
• 1 day: -8.69%
• 5 days: -13.16%
• 1 month: -21.3%
• 3 months: 169.69%
• 6 months: 161.1%
• Year to date: 146.22%
• 1 year: 203.06%
• 5 years: -89.98%
• 10 years: -93.71%
• Sector: Healthcare
• Industry: Biotechnology

About: Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.

Employees: 29